The Editor

The Editor

19
Oct

Stand Hits US$1B Valuation With US$70M to Insure Homes Built to Survive Disasters

Stand, a San Francisco-based home insurance company focused on areas exposed to natural disasters, has raised a US$70
3 min read
19
Oct

Archimed Buys Majority of Brazil's Genetica to Take Its Wastewater Biotech to the U.S.

Archimed, a French private equity firm that invests in healthcare and life sciences, has acquired a majority stake in Genetica
3 min read
16
Oct

Giraffe Bio: Argentine Startup Raises US$6.4M to Get More Copper From Existing Mines

Giraffe Bio, an Argentine biotech startup founded in 2024 by Alejandro Buffo Sempé and Juan Pablo Fernández, has raised a
3 min read
16
Oct

Dapta: Colombian-Founded Startup Raises US$6M to Put AI Sales Agents in Small Businesses

Dapta, an AI sales startup founded by Colombian entrepreneur Nicolás Rojas, announced on October 13, 2026, a US$6 million
3 min read
15
Oct

Labelbox: US$100M+ Series E to Train AI Models and Agents Through Practice

Labelbox, a San Francisco-based company that builds the training infrastructure behind advanced AI models, announced on October 14, 2026,
3 min read
15
Oct

Galderma Buys ZO Skin Health for US$1.5B to Deepen Its Reach Into U.S. Med Spas

Galderma, the Swiss dermatology company behind Cetaphil and Restylane, agreed on October 14, 2026 to buy ZO Skin Health from
3 min read
14
Oct

Scanntech: Uruguay's Retail Data Firm Raises US$180M to Expand Beyond Brazil

Scanntech, a Montevideo-based company that turns supermarket checkout data into market intelligence, announced a US$180 million Series F
3 min read
14
Oct

Koch Backs US$533M Getty Images Rescue After Failed Shutterstock Merger

Getty Images, the Seattle photo agency best known for its news and editorial photography, plans to file a prepackaged Chapter
3 min read
13
Oct

Ramp: Reported US$1.85B Round Values It at US$60B as It Builds AI Spending Agents

Ramp, a New York company that sells corporate cards and spending software to businesses, raised about US$1.85 billion
3 min read
13
Oct

Matchpoint Raises US$150M to Take Its Oral Autoimmune Pill Into Trials in 2027

Matchpoint Therapeutics, a biotech in Watertown, Massachusetts, raised a US$150 million Series B co-led by Nextech Invest and
3 min read